Apr 17, 2013 | Medical News
EKOS presents results of DUET trial at 35th Annual Charing Cross International Symposium
EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world's first and only multi-center randomized trial that compares ultrasound -accelerated, catheter -directed thrombolysis to standard side-hole, catheter-directed thrombolysis for the treatment of acute peripheral arterial ... (more)
DUET: Randomized, Controlled, Multi-Center Trial Demonstrates Reduced ...
EKOS Corporation, a privately held medical device company, announced the results of DUET, the world's first and only multi-center randomized trial that compares ultrasound-accelerated, catheter-directed thrombolysis to standard side-hole catheter-directed thrombolysis for the treatment of acute peripheral arterial thrombotic occlusions.
EKOS Corporation Announces U.S. Enrollment Completion of the SEATTLE...
EKOS Corporation , a privately held medical device company located in Bothell, Washington, announced today the completion of their second major trial for the treatment of pulmonary embolism .
World's First Pulmonary Embolism Trial Comparing Endovascular...
EKOS Corporation announced today that the results of the ULTIMA trial were presented at the American College of Cardiology meeting by Dr.